IrsiCaixa compta amb un centenar de projectes de recerca nacionals i internacionals actius cada any, finançats tant per entitats públiques com privades.
RETIRE HIV, P01 Role of reservoir composition and T cell immunity in HIV rebound kinetics
Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination — MISTRAL
IrsiCaixa (coordinator), Universite d’Aix Marseille, Region Hovedstaden, Case Western Reserve University Corporation, Karolinska Institutet, Projecte dels Noms-Hispanosida Asociacion, Consorci Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundación Privada Instituto de Salud Global Barcelona (ISGlobal), Asphalion SL., AELIX Therapeutics, SL, Vedanta Biosciences, Inc.
Horizon 2020 EU Framework Programme for Research and Innovation (Grant Agreement No. 847943)
HIV-specific immunity during treatment interruption (ATI) and its relationship to viral rebound and immune responses during acute HIV infection. New methos for ATI monituring in cure trials.